You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T cell receptor immunotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Leukemia, Myeloma Trial in Tampa (Resistance Training, Aerobic Exercise)

Recruiting
  • Lymphoma
  • +2 more
  • Resistance Training
  • Aerobic Exercise
  • Tampa, Florida
    Moffitt Cancer Center
Feb 28, 2023

Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

Not yet recruiting
  • Kidney Transplant
  • +2 more
  • Boston, Massachusetts
  • +2 more
Sep 20, 2023

CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

Active, not recruiting
  • Central Nervous System Tumor, Pediatric
  • +8 more
  • EGFR806-specific chimeric antigen receptor (CAR) T cell
  • Seattle, Washington
    Seattle Children's Hospital
Jan 18, 2023

Primary Mediastinal B-cell Lymphoma, Diffuse, Large B-cell Lymphoma, DLBCL Transformed From Follicular Lymphoma Trial run by the

Completed
Has Results
  • Primary Mediastinal B-cell Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 29, 2021

Cervical Cancer, Renal Cancer, Urothelial Cancer Trial run by the NCI (Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood

Completed
Has Results
  • Cervical Cancer
  • +4 more
  • Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2022

CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

Recruiting
  • Central Nervous System Tumor, Pediatric
  • +8 more
  • HER2-specific chimeric antigen receptor (CAR) T cell
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • BTK inhibitor
  • PD-1 inhibitor
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
May 20, 2023

Pancreatic Cancer, Cancer of the Pancreas Trial in Philadelphia (huCART-meso cells)

Recruiting
  • Pancreatic Cancer
  • Cancer of the Pancreas
  • huCART-meso cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Dec 9, 2022

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Leukemia, Lymphoma, Cardiotoxicity Trial in Philadelphia

Completed
  • Leukemia
  • +4 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jan 19, 2023

    Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

    Recruiting
    • Liver Cell Carcinoma
    • +7 more
    • CATCH T cells
    • +2 more
    • Houston, Texas
      Houston Methodist Hospital
    Dec 19, 2022

    Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

    Recruiting
    • Malignant Neoplasm
    • +4 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    CD 19+ Acute Leukemia Trial in Seattle (T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC))

    Active, not recruiting
    • CD 19+ Acute Leukemia
    • T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)
    • Seattle, Washington
      Seattle Children's Hospital
    Mar 22, 2022

    CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

    Recruiting
    • Central Nervous System Tumor
    • +10 more
    • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Anti-CD33 CAR T-cells
    • Lymphodepletion Therapy
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

    Terminated
    Has Results
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +12 more
    • Laboratory Biomarker Analysis
    • ROR1 CAR-specific Autologous T-Lymphocytes
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 11, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

    Recruiting
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +20 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 11, 2022

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

    Not yet recruiting
    • Cervical Cancer
    • +20 more
    • E7 TCR-T cells
    • New Brunswick, New Jersey
    • +1 more
    Jan 18, 2023

    Uterine Cervical Tumors Trial run by the NCI (E7 T-Cell Receptor (TCR))

    Terminated
    Has Results
    • Uterine Cervical Neoplasms
    • E7 T-Cell Receptor (TCR)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 7, 2021

    Papillomavirus Infections, Oropharyngeal Tumors Trial run by the NCI (E7 T-Cell Receptor (TCR))

    Terminated
    Has Results
    • Papillomavirus Infections
    • Oropharyngeal Neoplasms
    • E7 T-Cell Receptor (TCR)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 3, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

    Completed
    Has Results
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 3, 2022

    Hepatocellular Carcinoma Trial in Houston (GLYCAR T cells, Cytoxan, Fludarabine)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • GLYCAR T cells
    • +2 more
    • Houston, Texas
      Houston Methodist Hospital
    Feb 13, 2022

    B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)

    Active, not recruiting
    • B Cell Leukemia
    • Autologous CD19 CAR+ EGFTt + T cells
    • Seattle, Washington
      Seattle Children's Hospital
    Feb 15, 2022

    Glioma, Malignant Glioma of Brain, Recurrence Tumor Trial in Beijing (chimeric antigen receptor T cells)

    Recruiting
    • Glioma
    • +2 more
    • chimeric antigen receptor T cells
    • Beijing, China
      Xuanwu Hospital
    Jun 12, 2021